ANGLE appoints leading prostate cancer surgeon Greg Shaw as scientific advisor

03:34 EDT 14 May 2018 | Proactive Investors

The AIM-listed firm said Shaw brings significant additional prostate cancer and UK NHS clinical experience to its already established Scientific Advisory Board

More From BioPortfolio on "ANGLE appoints leading prostate cancer surgeon Greg Shaw as scientific advisor"